BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 32894194)

  • 1. The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1.
    Cervi F; Saletti V; Turner K; Peron A; Bulgheroni S; Taddei M; La Briola F; Canevini MP; Vignoli A
    Orphanet J Rare Dis; 2020 Sep; 15(1):237. PubMed ID: 32894194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural clusters of tuberous sclerosis complex (TSC)-associated neuropsychiatric disorders (TAND): new findings from the TOSCA TAND research project.
    de Vries PJ; Belousova E; Benedik MP; Carter T; Cottin V; Curatolo P; D'Amato L; Beure d'Augères G; Ferreira JC; Feucht M; Fladrowski C; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Marques R; Nabbout R; O'Callaghan F; Qin J; Sander V; Sauter M; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Kingswood JC; Jansen AC;
    J Neurodev Disord; 2020 Sep; 12(1):24. PubMed ID: 32873244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study.
    de Vries PJ; Belousova E; Benedik MP; Carter T; Cottin V; Curatolo P; Dahlin M; D'Amato L; d'Augères GB; Ferreira JC; Feucht M; Fladrowski C; Hertzberg C; Jozwiak S; Kingswood JC; Lawson JA; Macaya A; Marques R; Nabbout R; O'Callaghan F; Qin J; Sander V; Sauter M; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen AC;
    Orphanet J Rare Dis; 2018 Sep; 13(1):157. PubMed ID: 30201051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychiatric comorbidities in tuberous sclerosis complex patients with epilepsy: results of the TAND checklist survey.
    Lee HY; Lin CH; Wang XA; Tsai JD
    Acta Neurol Belg; 2024 Jun; 124(3):973-979. PubMed ID: 38523222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuropsychiatric manifestations in Tuberous Sclerosis Complex (TSC): diagnostic guidelines, TAND concept and therapy with mTOR inhibitors].
    Waltereit R; Feucht M; de Vries MC; Huemer J; Roessner V; de Vries PJ
    Z Kinder Jugendpsychiatr Psychother; 2019 Mar; 47(2):139-153. PubMed ID: 30080117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberous sclerosis-associated neuropsychiatric disorders: a paediatric cohort study.
    Toldo I; Brasson V; Miscioscia M; Pelizza MF; Manara R; Sartori S; Mantegazza G; Vecchi M; Nosadini M; Gatta M
    Dev Med Child Neurol; 2019 Feb; 61(2):168-173. PubMed ID: 30298907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders (TAND): New Findings on Age, Sex, and Genotype in Relation to Intellectual Phenotype.
    de Vries PJ; Belousova E; Benedik MP; Carter T; Cottin V; Curatolo P; Dahlin M; D'Amato L; Beaure d'Augères G; Ferreira JC; Feucht M; Fladrowski C; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Marques R; Nabbout R; O'Callaghan F; Qin J; Sander V; Sauter M; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Kingswood JC; Jansen AC;
    Front Neurol; 2020; 11():603. PubMed ID: 32733359
    [No Abstract]   [Full Text] [Related]  

  • 8. Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND Checklist.
    de Vries PJ; Whittemore VH; Leclezio L; Byars AW; Dunn D; Ess KC; Hook D; King BH; Sahin M; Jansen A
    Pediatr Neurol; 2015 Jan; 52(1):25-35. PubMed ID: 25532776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is It Feasible to Identify Natural Clusters of TSC-Associated Neuropsychiatric Disorders (TAND)?
    Leclezio L; Gardner-Lubbe S; de Vries PJ
    Pediatr Neurol; 2018 Apr; 81():38-44. PubMed ID: 29530301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberous Sclerosis Complex Patients' Needs and Difficulties-Results of TAND Questionnaire Analysis in Polish Adult Population.
    Marcinkowska AB; Jóźwiak S; Tarasewicz A; Dębska-Ślizień A; Szurowska E
    J Clin Med; 2022 Nov; 11(21):. PubMed ID: 36362764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical update on tuberous sclerosis complex-associated neuropsychiatric disorders (TAND).
    de Vries PJ; Wilde L; de Vries MC; Moavero R; Pearson DA; Curatolo P
    Am J Med Genet C Semin Med Genet; 2018 Sep; 178(3):309-320. PubMed ID: 30117265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberous Sclerosis Complex Associated Neuropsychiatric Disorders and Parental Stress: Findings from a National, Prospective TSC Surveillance Study.
    Ebrahimi-Fakhari D; Hussong J; Flotats-Bastardas M; Ebrahimi-Fakhari D; Zemlin M; von Gontard A; Meyer S
    Neuropediatrics; 2019 Oct; 50(5):294-299. PubMed ID: 31266065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of tuberous sclerosis-associated neuropsychiatric disorders using the MINI-KID tool: a pediatric case-control study.
    Ding Y; Wang J; Zhou H; Li T; Zhou S; Wang Y
    Orphanet J Rare Dis; 2021 Apr; 16(1):181. PubMed ID: 33865427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of Developmental and Behavioral Concerns in Toddlers With Tuberous Sclerosis Complex.
    McDonald NM; Jacobs S; Hyde C; Kasari C; Jeste SS
    Pediatr Neurol; 2024 Jun; 155():62-67. PubMed ID: 38603983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot validation of the tuberous sclerosis-associated neuropsychiatric disorders (TAND) checklist.
    Leclezio L; Jansen A; Whittemore VH; de Vries PJ
    Pediatr Neurol; 2015 Jan; 52(1):16-24. PubMed ID: 25499093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The research landscape of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)-a comprehensive scoping review.
    Vanclooster S; Bissell S; van Eeghen AM; Chambers N; De Waele L; Byars AW; Capal JK; Cukier S; Davis P; Flinn J; Gardner-Lubbe S; Gipson T; Heunis TM; Hook D; Kingswood JC; Krueger DA; Kumm AJ; Sahin M; Schoeters E; Smith C; Srivastava S; Takei M; Waltereit R; Jansen AC; de Vries PJ
    J Neurodev Disord; 2022 Feb; 14(1):13. PubMed ID: 35151277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral problems and family distress in tuberous sclerosis complex.
    Uematsu M; Numata-Uematsu Y; Aihara Y; Kobayashi T; Fujikawa M; Togashi N; Shiihara T; Ohashi K; Hattori A; Saitoh S; Kure S
    Epilepsy Behav; 2020 Oct; 111():107321. PubMed ID: 32698109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberous sclerosis complex-associated neuropsychiatric disorder (TAND) in a low-resource setting - From seizure to psychosis: A case report.
    Pokharel S; Jyotsana P; Maharjan RS; Singh R; Pandit K
    Ann Med Surg (Lond); 2020 Dec; 60():734-736. PubMed ID: 33425343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International consensus recommendations for the identification and treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND).
    de Vries PJ; Heunis TM; Vanclooster S; Chambers N; Bissell S; Byars AW; Flinn J; Gipson TT; van Eeghen AM; Waltereit R; Capal JK; Cukier S; Davis PE; Smith C; Kingswood JC; Schoeters E; Srivastava S; Takei M; Gardner-Lubbe S; Kumm AJ; Krueger DA; Sahin M; De Waele L; Jansen AC
    J Neurodev Disord; 2023 Sep; 15(1):32. PubMed ID: 37710171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep disorders and neuropsychiatric disorders in a pediatric sample of tuberous sclerosis complex: a questionnaire-based study.
    Moavero R; Voci A; La Briola F; Matricardi S; Toldo I; Mancardi MM; Negrin S; Messana T; Mazzone L; Valeriani M; Curatolo P; Bruni O
    Sleep Med; 2022 Jan; 89():65-70. PubMed ID: 34915263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.